Risk of elective major noncardiac surgery after coronary stent insertion: A population-based study

Circulation

Volumn 126, Issue 11, 2012, Pages 1355-1362

  Wijeysundera, Duminda N ^a,b,c,d   Wijeysundera, Harindra C ^c,d,e   Yun, Lingsong ^c   Wsowicz, Marcin ^b   Beattie, W Scott ^b   Velianou, James L ^f   Ko, Dennis T ^c,d,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

Author keywords

complications; coronary artery disease; percutaneous transluminal coronary angioplasty; surgery

Indexed keywords

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ANEURYSM SURGERY; ARTICLE; BARE METAL STENT; BYPASS SURGERY; CANADA; CAROTID ENDARTERECTOMY; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; CYSTECTOMY; DATA BASE; DISEASE REGISTRY; DRUG ELUTING STENT; ELECTIVE SURGERY; ESOPHAGUS RESECTION; FEMALE; GASTRECTOMY; HEART CATHETERIZATION; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; INTESTINE RESECTION; LIVER RESECTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PANCREATICODUODENECTOMY; PERCUTANEOUS CORONARY INTERVENTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; SURGICAL PATIENT; SURGICAL RISK; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; COHORT STUDIES; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; ONTARIO; REGISTRIES; RISK FACTORS; STENTS; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866237361     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.102715     Document Type: Article

References (38)

1. Gurevich Y, LeMay T, Capan DD, Herring J. Health indicators 2009: a focus on cardiac care in Canada. Healthc Q. 2010;13:18-21.
2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123: e18-e209.
3. Berger PB, Kleiman NS, Pencina MJ, Hsieh WH, Steinhubl SR, Jeremias A, Sonel A, Browne K, Barseness G, Cohen DJ, and EVENT Investigators. Frequency of major noncardiac surgery and subsequent adverse events in the year after drug-eluting stent placement results from the EVENT (Evaluation of Drug-Eluting Stents and Ischemic Events) Registry. J Am Coll Cardiol Cardiovasc Interv. 2010;3:920-927.
4. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H. Coronary artery stenting and non-cardiac surgery-a prospective outcome study. Br J Anaesth. 2006;96:686-693.
5. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ. 2005;173: 627-634.
6. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet. 2008;371:1839-1847.
7. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SCJ, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2007;116: e418-e499.
8. Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof EL, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009; 120:e169-e276.
9. Epstein AJ, Polsky D, Yang F, Yang L, Groeneveld PW. Coronary revascularization trends in the United States, 2001-2008. JAMA. 2011; 305:1769-1776.
10. Cruden NL, Harding SA, Flapan AD, Graham C, Wild SH, Slack R, Pell JP, Newby DE. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv. 2010; 3:236-242.
11. Kałuza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000;35:1288-1294.
12. Nuttall GA, Brown MJ, Stombaugh JW, Michon PB, Hathaway MF, Lindeen KC, Hanson AC, Schroeder DR, Oliver WC, Holmes DR, Rihal CS. Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology. 2008;109:588-595.
13. Wilson SH, Fasseas P, Orford JL, Lennon RJ, Horlocker T, Charnoff NE, Melby S, Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting. J Am Coll Cardiol. 2003;42:234-240.
14. Ko DT, Chiu M, Guo H, Austin PC, Goeree R, Cohen E, Labinaz M, Tu JV. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off-and on-label indications. J Am Coll Cardiol. 2009;53: 1773-1782.
15. Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R. Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med. 2007;357: 1393-1402.
16. Austin PC, Daly PA, Tu JV. A multicenter study of the coding accuracy of hospital discharge administrative data for patients admitted to cardiac care units in Ontario. Am Heart J. 2002;144:290-296.
17. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care. 2002;25:512-516.
18. Juurlink D, Preya C, Croxford R, Chong A, Austin P, Tu J, Laupacis A. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. ICES Investigative Report. Toronto, ON: Institute for Clinical Evaluative Sciences; 2006.
19. Tu K, Campbell NRC, Chen ZL, Cauch-Dudek KJ, McAlister FA. Accuracy of administrative databases in identifying patients with hypertension. Open Medicine. 2007;1:E18-E26.
20. Williams JI, Young W. Appendix: a summary of studies on the quality of health care administrative databases in Canada. In: Goel V, Williams JI, Anderson GM, Blackstein-Hirsch P, Fooks C, Naylor CD, eds. Patterns of Health Care in Ontario. The ICES Practice Atlas. Ottawa, ON: Canadian Medical Association; 1996.
21. Technical Supplement: Health Care in Canada 2005. Ottawa, ON: Canadian Institute for Health Information; 2005.
22. Bourne RB, DeBoer D, Hawker G, Kreder H, Mahomed N, Paterson JM, Warner S, Williams J. Chapter 5: Total hip and knee replacement. In: Tu JV, Pinfold SP, McColgan P, Laupacis A, eds. Access to Health Service in Ontario: ICES Atlas. Toronto, ON: Institute for Clinical Evaluative Sciences; 2005.
23. Warner MA, Shields SE, Chute CG. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. JAMA. 1993;270: 1437-1441.
24. Ko DT, Newman AM, Alter DA, Austin PC, Chiu M, Cox JL, Goodman SG, Tu JV. Secular trends in acute coronary syndrome hospitalization from 1994 to 2005. Can J Cardiol. 2010;26:129-134.
25. Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130-1139.
26. du Plessis V, Beshiri R, Bollman RD, Clemeson H. Definitions of "rural." Agriculture and Rural Working Paper Series, No. 61. Ottawa, ON: Statistics Canada; 2002.
27. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043-1049.
28. Auerbach A, Goldman L. Assessing and reducing the cardiac risk of noncardiac surgery. Circulation. 2006;113:1361-1376.
29. Noordzij PG, Poldermans D, Schouten O, Bax JJ, Schreiner FA, Boersma E. Postoperative mortality in The Netherlands: a population-based analysis of surgery-specific risk in adults. Anesthesiology. 2010;112: 1105-1115.
30. Ueda Y, Nanto S, Komamura K, Kodama K. Neointimal coverage of stents in human coronary arteries observed by angioscopy. J Am Coll Cardiol. 1994;23:341-346.
31. Weintraub WS. The pathophysiology and burden of restenosis. Am J Cardiol. 2007;100:3K-9K.
32. Assali A, Vaknin-Assa H, Lev E, Bental T, Ben-Dor I, Teplitsky I, Brosh D, Fuchs S, Eidelman L, Battler A, Kornowski R. The risk of cardiac complications following noncardiac surgery in patients with drug eluting stents implanted at least six months before surgery. Catheter Cardiovasc Interv. 2009;74:837-843.
33. Brotman DJ, Bakhru M, Saber W, Aneja A, Bhatt DL, Tillan-Martinez K, Jaffer AK. Discontinuation of antiplatelet therapy prior to low-risk noncardiac surgery in patients with drug-eluting stents: a retrospective cohort study. J Hosp Med. 2007;2:378-384.
34. Rabbitts JA, Nuttall GA, Brown MJ, Hanson AC, Oliver WC, Holmes DR, Rihal CS. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. 2008;109: 596-604.
35. Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, Bonizzoni E, Carlino M, Gerckens U, Godino C, Melzi G, Michev I, Montorfano M, Sangiorgi GM, Qasim A, Chieffo A, Briguori C, Grube E. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation. 2007;116: 745-754.
36. Godet G, Le Manach Y, Lesache F, Perbet S, Coriat P. Drug-eluting stent thrombosis in patients undergoing non-cardiac surgery: is it always a problem? Br J Anaesth. 2008;100:472-477.
37. Romano PS, Schembri ME, Rainwater JA. Can administrative data be used to ascertain clinically significant postoperative complications? Am J Med Qual. 2002;17:145-154.
38. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2006;47:e1-e121.